Table 2 of Al-Bdour, Mol Vis 2020; 26:445-458.


Table 2. Clinical examination results for participants with RLBP1 variants.

Index Identified gene; HGVSaa Age Nyctalopia (age) Peripheral vision loss (age) Central vision loss (age) VA /BCVA Slit lamp Biomicroscopy Keratoconus ffERG OCT evaluation Further clinical evaluation data
F4-V10 RLBP1; p.Thr27ProfsTer26 30 Y (2) Paracentral vision better than peripheral vision Para-central vision better than central vision OD:CF 1m/ NI OS:CF closely/ NI OD/ OS: Clear lens OD: N OS: N OD/ OS: Severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy Photophobia
F4-V11 RLBP1; p.Thr27ProfsTer26 28 Y (2) Paracentral vision better than peripheral vision Para-central vision better than central vision OD:0.05/ NI OS:0.05/ NI OD/ OS: Clear lens OD: N OS: N OD/ OS: Severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy Photophobia
F4-V12 RLBP1; p.Thr27ProfsTer26 26 Y (2) Paracentral vision better than peripheral vision Para-central vision better than central vision OD:CF closely/ 0.1 OS:CF 2m/ NI OD/ OS: Clear lens OD: N OS: N OD/ OS: Severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy Photophobia
F4-V13 RLBP1; p.Thr27ProfsTer26 34 Y (2) Paracentral vision better than peripheral vision Para-central vision better than central vision OD:CF 2.5m/ NI OS:CF 2.5m/ NI OD/ OS: Congen-ital blue dots cataract OD: N OS: N OD/ OS: Moderate to severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy Photophobia
F5-V5 RLBP1; p.Pro133GlnfsTer126 60 Y (2) Y (35) Y (50) OD: CF closely/ NI OS: CF closely/ NI OD/ OS: Nuclear sclerosis OD: N OS: N OD/ OS: Severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy -
F5-V6 RLBP1; p.Pro133GlnfsTer126 51 Y (2) Y (27) Y (41) OD: HM/ NI OS: HM/ NI OD/OS: Mild PSCC OD: N
OS: N OD/OS: Severe reduced scotopic and photopic responses OD/ OS: Atrophic maculopathy